Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast

British Journal of Cancer

Volumn 73, Issue 5, 1996, Pages 636-639

  Munn, K E ^a   Walker, R A ^b   Menasce, L ^a   Varley, J M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

BRCA1 gene; Ductal carcinoma in situ; Imbalance; Microdissection

Indexed keywords

ALLELE; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER INVASION; CARCINOMA IN SITU; CHROMOSOME 17Q; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030023958     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.110     Document Type: Article

References (27)

1. BETSILL WL, ROSEN PP, LIEBERMAN PH AND ROBBINS GF. (1978). Intraductal carcinoma: long-term follow-up after treatment by biopsy alone. JAMA, 239, 1863-1867.
2. BORG A, ZHANG Q-X, JOHANNSSON O AND OLSSON H. (1994). High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas. J. Natl Cancer Inst., 86, 792-794.
3. CORNELIS RS, DEVILEE P, VAN VLIET M, KUIPERS-DIJKSHOORN N, KERSENMAEKER A, BARDOEL A, MEERA KHAN P AND CORNELISSE CJ. (1993). Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions. Oncogene, 8, 781-785.
4. CROPP CS, CHAMPEME M-H, LIDEREAU R AND CALLAHAN R. (1993). Identification of three regions on chromosome 17q in human primary breast carcinomas which are frequently deleted. Cancer Res., 53, 5617-5619.
5. DUPONT WD AND PAGE DL. (1985). Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med., 312, 146-151.
6. ELSTON CW AND ELLIS IO. (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19, 403-410.
7. FUTREAL PA, SODERKVIST P, MARKS JR, IGLEHART JD, COCHRAN C, BARRETT JC AND WISEMAN RW. (1992). Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res., 52, 2624-2627.
8. FUTREAL PA, LIU Q, SHATTUCK-EIDENS D, COCHRAN C, HARSHMAN K, TAVTIGIAN S, BENNETT LM, HAUGEN-STRANO A, SWENSEN J, MIKI Y, EDDINGTON K, MCCLURE M, FRYE C, WEAVER-FELDHAUS J, DING W, GHOLAMI Z, SODERKVIST P, TERRY L, JHANWAR S, BERCHUCK A, IGLEHART JD, MARKS J, BALLINGER DG, BARRETT JC, SKOLNICK MH, KAMB A AND WISEMAN R. (1994). BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122.
9. HALL JM, FRIEDMAN L, GUENTHER C, LEE MK, WEBER JL, BLACK DM AND KING M-C. (1992). Closing in on a breast cancer gene on chromosome 17q. Am. J. Hum. Genet., 50, 1235-1242.
10. HOGGARD N, BRINTNELL B, HOWELL A, WEISSENBACH J AND VARLEY JM. (1995). Allelic imbalance on chromosome 1 in human breast cancer. II. Microsatellite repeat analysis. Genes, Chrom. Cancer, 12, 24-31.
11. LEONE A, MCBRIDE OW, WESTIN A, WANG M, ANGLARD P, CROPP CS, LINEHAN MW, REES R, CALLAHAN R, HARRIS C, LIOTTA LA AND STEEG PS. (1991). Somatic allele deletion of nm23 in human cancer. Cancer Res., 51, 2490-2493.
12. LIU E, THOR A, HE M, BARCOS M, LJUNG B-M AND BENZ C. (1992). The HER2(c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene, 7, 1027-1032.
13. MERAJVER S, PHAM TM, CADUFF RF, CHEN M, POY EL, COONEY KA, WEBER BL, COLLINS FS, JOHNSTON C AND FRANK TS. (1995). Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genetics, 9, 439-443.
14. MIKI Y, SWENSEN J, SHATTUCK-EIDENS D, FUTREAL PA, HARSHMAN K, TAVTIGIAN S, LIU Q, COCHRAN C, BENNETT LM, DING W, BELL R, ROSENTHAL J, HUSSEY C, TRAN T, MCCLURE M, FRYE C, HATTIER T, PHELPS R, HAUGEN-STRANO A, KATCHER H, YAKUMO K, GHOLAMI Z, SHAFFER D, STONE S, BAYER S, WRAY C, BOGDEN R, DAYANANTH P, WARD J, TONIN P, NAROD S, BRISTOW PK, NORRIS FH, HELVERING L, MORRISON P, ROSTECK P, LAI M, BARRETT JC, LEWIS C, NEUHAUSEN S, CANNON-ALBRIGHT L, GOLDGAR D, WISEMAN R, KAMB A AND SKOLNICK MH. (1994). A strong candidate for the breast, and ovarian cancer susceptibility gene BCRA1. Science, 266, 66-71.
15. MUNN KE, WALKER RA AND VARLEY JM. (1996). Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ, (manuscript in preparation).
16. MUNN KE, WALKER RA AND VARLEY JM. (1995). Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 10, 1653-1657.
17. PAGE DL, DUPONT WD, ROGERS LW AND LANDENBERGER M. (1982). Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer, 49, 751-758.
18. POLYMEROPOULOS MH, RATH DS, XIAO H AND MERILL CR. (1991). A simple sequence repeat polymorphism at the human growth hormone locus. Nucleic Acids Res., 19, 689.
19. PONDER B. (1988). Gene losses in human tumours. Nature, 335, 400-402.
20. RADFORD DM, FAIR K, THOMPSON AM, RITTER JH, HOLT M, STEINBRUECK T, WALLACE M, WELLS SA AND DONIS-KELLER HR. (1993). Allelic loss on chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res., 53, 2947-2950.
21. ROSEN PP, BRAUN DW AND KINNE DE. (1980). The clinical significance of pre-invasive breast carcinoma. Cancer, 46, 919-925.
22. ROYDS JA, STEPHENSON TJ, REES RC, SHORTHOUSE AJ AND SILCOCKS PB. (1993). Nm23 protein expression in ductal carcinoma in situ and invasive human breast carcinoma. J. Natl Cancer Inst., 85, 72-76.
23. SATO T, SAITO H, SWENSEN J, OLIFANT A, WOOD C, DANNER D, SAKAMOTO T, TAKITA K, KASUMI F, MIKI Y, SKOLNICK M AND NAKAMURA Y. (1992). The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res., 52, 1643-1646.
24. STRATTON MR, COLLINS N, LAKHANI SR AND SLOANE JP. (1995). Loss of heterozygosity in ductal carcinoma in situ of the breast. J. Pathol., 175, 195-201.
25. TAVASSOLI FA AND NORRIS HJ. (1990). A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer, 65, 518-529.
26. VAN DONGEN JA, HOLLAND R, PETERSE JL, FENTIMAN IS, LAGIOS MD, MILLIS RR AND RECHT A. (1992). Ductal carcinoma in situ of the breast; second EORTC consensus meeting. Eur. J. Cancer, 28, 626-629.
27. WEBER JL, KWITEK AE, MAY PE, WALLACE MR, COLLINS FS AND LEDBETTER DH. (1990). Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res., 18, 4640.